Astellas is banging the drum for patient advocacy organizations (PAOs) again. One year after coordinating the first PAO Action Week, the Japanese drugmaker is gearing up for the second edition of an ...

This community-driven initiative — coordinated by volunteer staff members from Astellas — brings together a diverse coalition of life sciences companies, healthcare organizations, patient advocacy ...

This study examined patient and public involvement and engagement (PPIE) in allergy research in Japan through a comparative survey of patient advocacy groups (PAGs) and principal investigators (PIs).

Patient advocates are asking a federal appeals court to crack down on third-party vendors that obtain prescription drugs from overseas for U.S. patients, arguing the practice exposes them to unsafe ...

Where are you seeing the biggest shifts in patient-centricity across pharma? One of the most significant shifts I’ve observed is how early in the development process companies are engaging individuals ...